Old Web
English
Sign In
Acemap
>
authorDetail
>
Lisa DiCicco
Lisa DiCicco
University of Pennsylvania
Internal medicine
Medicine
Oncology
Galunisertib
Hepatocellular carcinoma
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of regorafenib, hydroxychloroquine, and entinostat in metastatic colorectal cancer.
2021
Journal of Clinical Oncology
Timothy J Brown
Thomas Benjamin Karasic
Charles Schneider
Ursina R. Teitelbaum
Kim A. Reiss
Tara C. Mitchell
Ryan Massa
Mark H. OHara
Lisa DiCicco
Luis Garcia-Marcano
Ravi K. Amaravadi
Peter J. ODwyer
Show All
Source
Cite
Save
Citations (0)
A Pilot Study of Galunisertib Plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.
2020
Molecular Cancer Therapeutics
Kim A. Reiss
Max M. Wattenberg
Nevena Damjanov
Elizabeth Prechtel Dunphy
Mona Jacobs-Small
M. Judy Lubas
James Robinson
Lisa DiCicco
Luis Garcia-Marcano
Michael A Giannone
Thomas Benjamin Karasic
Emma E. Furth
Erica L. Carpenter
A.P. Wojcieszynski
Robert H. Vonderheide
Gregory L. Beatty
Edgar Ben-Josef
Show All
Source
Cite
Save
Citations (3)
Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC).
2020
Journal of Clinical Oncology
Max M. Wattenberg
Kim A. Reiss
Michael Giannone
Nevena Damjanov
Elizabeth Prechtel Dunphy
Lisa DiCicco
Luis Garcia-Marcano
Thomas Benjamin Karasic
Emma E. Furth
A.P. Wojcieszynski
Robert H. Vonderheide
Edgar Ben-Josef
Gregory L. Beatty
Show All
Source
Cite
Save
Citations (0)
1